| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Hughes-Wilson Alexandra is a See Remarks at MREO. Recent filings cover 0 purchases and 8 sales. Those positions are worth an estimated $568K at current prices.
Our model assigns Hughes-Wilson Alexandra a middling insider score of 65/100, based on 5 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +35.7%.
Hughes-Wilson Alexandra's largest disclosed position is in MREO as See Remarks, worth about $568K. The recent filings there lean toward selling, a net 281,644 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 13, 2024 | MREO Mereo Biopharma Group Plc | See Remarks | Sell | 148,110 | $4.30 | $637,203.07 | -74.6% | -12.9% | -56.8% | |
| Jun 26, 2024 | MREO Mereo Biopharma Group Plc | See Remarks | Sell | 33,102 | $3.49 | $115,369.00 | -48.9% | +16.0% | -19.8% | |
| May 22, 2024 | MREO Mereo Biopharma Group Plc | See Remarks | Sale+OE | 100,432 | $2.97 | $297,787.58 | -75.5% | +48.5% | -23.7% |